Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Demant AS | Salute | Max Jousma | Equity Analyst | 13/06/2025 | ||
Cardinal Health Inc | Salute | Keonhee Kim | Equity Analyst | 12/06/2025 | ||
Cochlear Ltd | Salute | Shane Ponraj | Equity Analyst | 12/06/2025 | ||
Steris PLC | Salute | Jay Lee | Senior Equity Analyst | 06/06/2025 | ||
CRISPR Therapeutics AG | Salute | Rachel Elfman | Equity Analyst | 05/06/2025 | ||
Celltrion Inc | Salute | Yurou Zheng | Equity Analyst | 05/06/2025 | ||
Sanofi SA | Salute | Jay Lee | Senior Equity Analyst | 02/06/2025 | ||
Sanofi SA ADR | Salute | Jay Lee | Senior Equity Analyst | 02/06/2025 | ||
BioNTech SE ADR | Salute | Karen Andersen | Director | 02/06/2025 | ||
Bristol-Myers Squibb Co | Salute | Karen Andersen | Director | 02/06/2025 | ||
Moderna Inc | Salute | Karen Andersen | Director | 02/06/2025 | ||
Genmab AS | Salute | Rachel Elfman | Equity Analyst | 30/05/2025 | ||
Regeneron Pharmaceuticals Inc | Salute | Jay Lee | Senior Equity Analyst | 30/05/2025 | ||
Lonza Group Ltd | Salute | Rachel Elfman | Equity Analyst | 30/05/2025 | ||
CSPC Pharmaceutical Group Ltd | Salute | Yurou Zheng | Equity Analyst | 30/05/2025 | ||
The Cooper Companies Inc | Salute | Keonhee Kim | Equity Analyst | 30/05/2025 | ||
Intellia Therapeutics Inc | Salute | Rachel Elfman | Equity Analyst | 30/05/2025 | ||
Teva Pharmaceutical Industries Ltd ADR | Salute | Keonhee Kim | Equity Analyst | 29/05/2025 | ||
Agilent Technologies Inc | Salute | Julie Utterback | Senior Equity Analyst | 29/05/2025 | ||
Veeva Systems Inc Class A | Salute | Keonhee Kim | Equity Analyst | 29/05/2025 |